LAPTM5 and glioblastoma: Additionally, LAPTM5 inhibited the clonogenicity of U87MG glioblastoma cells as LAPTM5 knockdown cells demonstrated a significantly higher clonogenic capacity compared to the respective vector control cells (Figure 1C).